Neuro Biomed Corporation
Neuro Biomed Corporation (Neuro Biomed) is a bio-pharmaceutical company that is engaged in the design and development of the hormone related testing reagents and drug delivery devices for the in-vitro diagnostic markets. It develops NB-3108, a novel neuroprotective agent that is used for acute treatment of stroke and traumatic brain injury (TBI) and also for prophylactic treatment of neurological damage associated with coronary artery bypass graft (CABG). Neuro Biomed`s NanoBio Drug Delivery System is utilized for drug delivery and diagnostic applications. Its pharmaceutical products are utilized for regeneration of cells and tissue with its ability to repair damage caused by disease or trauma. The company is headquartered at California, the US.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

